01/03/2013

Strategie per il trattamento del tumore mammario triplo-negativo

"Triple negative breast cancer (TNBC) is a minor subtype and has distinctive aspect of clinical behavior. TNBC often shows rapid and expanding growth pattern, unlike luminal type. Chemotherapy is the only method as systemic therapy and shows remarkable effect with relatively high probability; to the contrary, some of TNBCs show overt progression in a short period during chemotherapy and develop early recurrence with short survival. Various molecular targeting therapies are developing, but do not reach our daily practice. So we tried to explore effective ways of treatment for TNBC from both previous reports and our experiences in the literature. We need to consider effective treatment strategy for TNBC, including local therapy as well as systemic therapy with special care"  
(Comment on:  Yagata H et al.: "Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy", Breast Cancer. 2011 Feb 3. [Epub ahead of print])

Condividi
Altri articoli

Complicanze post-chirurgiche nelle pazienti operate per carcinoma mammario e aspetti riabilitativi

Condividi

Alterazioni del ritmo circadiano e rischio di carcinoma mammario

Condividi

Cadmio e rischio di neoplasia mammaria

Condividi

Radioterapia con protoni in donne affette da neoplasia mammaria

Condividi

L'antiepilettico fenitoina riduce la crescita cellulare e le metastasi del tumore mammario

Condividi